Pharmaceutical Pricing Reforms: Developments, Legislation and Risk Mitigation
Weil Antitrust partner Eric Hochstadt served as a moderator for a panel at GCR Live: Antitrust in Pharmaceuticals to discuss recent developments in pharmaceutical pricing, including legislation, regulations, industry responses, and the potential impact of the FTC’s focus on Pharmacy Benefit Managers (PBMs).
Event Name
Pharmaceutical Pricing Reforms: Developments, Legislation and Risk Mitigation
Details
Date: October 29, 2024 - October 29, 2024
Location: New York, New York
